HMGN1P32

Across TCGA pan-cancer cohorts, HMGN1P32 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of HMGN1P32’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where HMGN1P32 RNA is repressed in tumor relative to normal tissue. In most cancer types HMGN1P32 is over-expressed in tumor, although a few such as LIHC show the opposite, repressed pattern.

LIHC are the cancer types where HMGN1P32 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in HMGN1P32 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	All	−0.018	.043	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

HMGN1P32–LIHC

Open the LIHC breakdown →